We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
(+1.3%)
Cap. Flow
-$819M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.06B |
| 2 |
UnitedHealth
UNH
|
+$935M |
| 3 |
Uber
UBER
|
+$426M |
| 4 |
Boeing
BA
|
+$312M |
| 5 |
Salesforce
CRM
|
+$309M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Meta Platforms (Facebook)
META
|
+$644M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$628M |
| 4 |
GE Vernova
GEV
|
+$439M |
| 5 |
Eli Lilly
LLY
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.14% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 8.46% |
| 5 | Industrials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Kyverna Therapeutics
KYTX
$481M
| $57K | ﹤0.01% |
15,241
-16,982
| -53% | -$81.4K |
|
2452
LivePerson
LPSN
$20.8M
| $56.7K | ﹤0.01% |
+2,486
| New | +$38K |
|
2453
PUT
Bank of America
BAC
$436B
| $52.7K | ﹤0.01% |
+1,200
| New | +$52.8K |
|
2454
Identive
INVE
$65.1M
| $50.7K | ﹤0.01% |
+13,855
| New | +$51.9K |
|
|
FLNA
2455
Filana Therapeutics
FLNA
$43.5M
| $49.8K | ﹤0.01% |
+21,093
| New | +$370K |
|
2456
Immuneering
IMRX
$282M
| $47.1K | ﹤0.01% |
+21,432
| New | +$44.4K |
|
|
YSG
2457
Yatsen Holding
YSG
$318M
| $47K | ﹤0.01% |
+11,801
| New | +$48.7K |
|
2458
Entravision Communication
EVC
$1.02B
| $45.1K | ﹤0.01% |
+19,200
| New | +$44.9K |
|
2459
Comtech Telecommunications
CMTL
$54.5M
| $43.8K | ﹤0.01% |
+10,917
| New | +$39K |
|
2460
Mammoth Energy Services
TUSK
$131M
| $42.5K | ﹤0.01% |
+14,163
| New | +$52.2K |
|
|
NIU
2461
Niu Technologies
NIU
$209M
| $42.1K | ﹤0.01% |
+23,512
| New | +$50.6K |
|
2462
Vor Biopharma
VOR
$1.05B
| $41.3K | ﹤0.01% |
1,860
-3,972
| -68% | -$65.8K |
|
2463
Information Services Group
III
$192M
| $41.1K | ﹤0.01% |
+12,309
| New | +$41.1K |
|
2464
Adicet Bio
ACET
$75.3M
| $38.7K | ﹤0.01% |
2,519
-6,556
| -72% | -$124K |
|
|
ABVEW
2465
CALL
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
| $37.8K | ﹤0.01% |
70,000
-30,773
| -31% | -$646 |
|
2466
Century Therapeutics
IPSC
$377M
| $35.9K | ﹤0.01% |
+35,511
| New | +$48.3K |
|
|
CKPT
2467
DELISTED
Checkpoint Therapeutics
CKPT
| $35.8K | ﹤0.01% |
11,172
-51,531
| -82% | -$175K |
|
|
2468
CALL
Boeing
BA
$167B
| $35.4K | ﹤0.01% |
+200
| New | +$31.4K |
|
2469
Sana Biotechnology
SANA
$913M
| $34.8K | ﹤0.01% |
21,322
-372,359
| -95% | -$1.11M |
|
2470
Merck
MRK
$323B
| $32.9K | ﹤0.01% |
331
-3,029
| -90% | -$312K |
|
2471
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
| $25.2K | ﹤0.01% |
+600
| New | +$27.8K |
|
|
NOTE
2472
DELISTED
FiscalNote
NOTE
| $24.5K | ﹤0.01% |
1,908
-45,493
| -96% | -$554K |
|
2473
CALL
Advanced Micro Devices
AMD
$807B
| $24.2K | ﹤0.01% |
200
-2,000
| -91% | -$288K |
|
2474
Smart Sand
SND
$203M
| $23.2K | ﹤0.01% |
+10,303
| New | +$23K |
|
2475
Biodesix
BDSX
$230M
| $23K | ﹤0.01% |
+753
| New | +$22.2K |
|
Similar funds
Marshall Wace's Q4 2024 Portfolio in Review
As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
- Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
- Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
- Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
- Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
- Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.
Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.